Education
About Us
Working with TipRanks
Follow Us
DiagnosTear Technologies, Inc. (TSE:DTR)
:DTR
RESEARCH TOOLSreports
DTR Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.20 - C$0.75
Previous CloseN/A
Volume500.00
Average Volume (3M)32.96K
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-1.66
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding58,788,334
10 Day Avg. Volume589
30 Day Avg. Volume32,961
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
DiagnosTear Technologies, Inc. News
DTR FAQ
What was DiagnosTear Technologies, Inc.’s price range in the past 12 months?
DiagnosTear Technologies, Inc. lowest stock price was C$0.20 and its highest was C$0.75 in the past 12 months.
What is DiagnosTear Technologies, Inc.’s market cap?
Currently, no data Available
When is DiagnosTear Technologies, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were DiagnosTear Technologies, Inc.’s earnings last quarter?
Currently, no data Available
Is DiagnosTear Technologies, Inc. overvalued?
According to Wall Street analysts DiagnosTear Technologies, Inc.’s price is currently Overvalued.
Does DiagnosTear Technologies, Inc. pay dividends?
DiagnosTear Technologies, Inc. does not currently pay dividends.
What is DiagnosTear Technologies, Inc.’s EPS estimate?
DiagnosTear Technologies, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does DiagnosTear Technologies, Inc. have?
DiagnosTear Technologies, Inc. has 58,788,334 shares outstanding.
What happened to DiagnosTear Technologies, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of DiagnosTear Technologies, Inc.?
Currently, no hedge funds are holding shares in TSE:DTR
Company Description
DiagnosTear Technologies, Inc.
DiagnosTear is focused on the diagnosis of front-of-the-eye diseases at the point of care, by analyzing the composition of the tear fluid using its proprietary non invasive TeaRx¿ technology and currently has two products for diagnosis of Dry Eye Disease and Red Eye causes.
DiagnosTear Technologies, Inc. (DTR) Earnings & Revenues
Currently, no data available
Please return soon. This page is being updated.
Technical Analysis
Diagnos
―
StageZero Life Sciences Ltd
―
Helix BioPharma
―
Core One Labs
―
Microbix Biosystms
―